Dose Escalation of HSP990 in Japan/Korea

NCT01064089 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: HSP990

Sponsor

Novartis Pharmaceuticals